The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(3'-ethyl-4'-pyridyl)carboxamido]morphinan ID: ALA4569785
PubChem CID: 154594323
Max Phase: Preclinical
Molecular Formula: C28H33N3O4
Molecular Weight: 475.59
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cnccc1C(=O)N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Standard InChI: InChI=1S/C28H33N3O4/c1-2-17-14-29-11-8-19(17)26(33)30-20-7-9-28(34)22-13-18-5-6-21(32)24-23(18)27(28,25(20)35-24)10-12-31(22)15-16-3-4-16/h5-6,8,11,14,16,20,22,25,32,34H,2-4,7,9-10,12-13,15H2,1H3,(H,30,33)/t20-,22-,25+,27+,28-/m1/s1
Standard InChI Key: JAGRUTRHAYBFKA-RDGDOILBSA-N
Molfile:
RDKit 2D
37 43 0 0 0 0 0 0 0 0999 V2000
13.8616 -13.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2700 -12.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0367 -13.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2700 -14.0449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6367 -14.0575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4200 -14.5324 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9116 -11.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6242 -12.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8366 -11.0951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0241 -11.9117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4325 -12.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0865 -12.6242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0865 -14.0491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8076 -14.0616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4200 -11.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7992 -12.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5073 -13.3367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6741 -11.8993 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3868 -13.3491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0740 -10.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2365 -10.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3868 -14.7865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2616 -14.9616 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
14.6241 -11.5368 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
15.8055 -10.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7931 -9.9156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4937 -14.7666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3185 -14.7728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7256 -15.4903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7363 -14.0615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3053 -16.1970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7117 -16.9140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5376 -16.9207 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9552 -16.2043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5465 -15.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9602 -14.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7851 -14.7780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 3 2 0
6 4 1 0
7 2 1 0
8 3 1 0
9 15 1 0
10 8 1 0
1 11 1 1
12 2 1 0
13 4 1 0
14 5 1 0
15 11 1 0
16 8 2 0
17 13 1 0
2 18 1 1
19 16 1 0
20 21 1 0
21 9 1 0
22 14 1 0
4 23 1 1
7 24 1 6
6 5 1 0
7 9 1 0
17 12 1 0
7 10 1 0
19 14 2 0
25 20 1 0
26 25 1 0
20 26 1 0
13 27 1 1
27 28 1 0
28 29 1 0
28 30 2 0
29 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 29 1 0
35 36 1 0
36 37 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 475.59Molecular Weight (Monoisotopic): 475.2471AlogP: 2.71#Rotatable Bonds: 5Polar Surface Area: 94.92Molecular Species: BASEHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.29CX Basic pKa: 9.51CX LogP: 2.11CX LogD: 0.29Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.62Np Likeness Score: 0.68
References 1. Zheng Y, Obeng S, Wang H, Jali AM, Peddibhotla B, Williams DA, Zou C, Stevens DL, Dewey WL, Akbarali HI, Selley DE, Zhang Y.. (2019) Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands., 62 (2): [PMID:30608693 ] [10.1021/acs.jmedchem.8b01158 ]